
Nicolas Wolikow
Health Tech Innovator | Scaling Startups with $200M Revenue Experience
Mezzo is a public record of who has spoken where, built from conference lineups. What is Mezzo?
Most recently at Slush in 2024.

About
Nicolas Wolikow transformed complex healthcare challenges into strategic opportunities. With over 20 years leading digital business development across startups and multinational firms, he has consistently delivered exceptional revenue generation and strategic leadership.
As Co-founder and CEO of Cure51, Wolikow is pioneering innovative healthcare technology platforms that reshape how medical solutions are developed and scaled. His expertise spans managing multi-million dollar business divisions, creating digital marketplaces, and driving transformative technological innovations in life sciences.
Featured1 with video
Nicolas Wolikow, Co-founder & CEO, Cure51 | Slush 2025
Health-Drug & Treatment Discovery: Nicolas Wolikow, Co-founder & CEO, Cure51 Slush is the most founder-focused event on Earth, delivering actionable company-building advice while bringing...
2 talks, all in 2024
This is only what we could find published. Nicolas has almost certainly done more.
Is this you?
Claim this profile to edit your bio, add talks, and get verified.
Free. We don't charge speakers to be listed.
Know a talk we're missing?
At a Glance
Booking Nicolas
Mezzo doesn't take bookings or publish speaking fees.
To book Nicolas or ask what they charge, contact them or their agent directly. We don't have their details yet.
Booked before by Slush.
Save for Later
Similar Speakers
Related by topic and shared stages
Explore related directories
Conferences, directories, and industries connected to Nicolas Wolikow



.jpg)